STOCK TITAN

Clover Health (CLOV) CEO’s 313,476-share sale tied to RSU tax withholding

(Very High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Clover Health Investments, Corp. Chief Executive Officer Andrew Toy reported an open-market sale of 313,476 shares of Class A common stock at $5.32 per share. According to the disclosure, these shares were sold solely to cover tax withholding obligations tied to the vesting of 6.25% of restricted stock units granted on January 1, 2023, under a mandatory “sell to cover” arrangement in the company’s equity incentive plans. Following the transaction, Toy directly owns 9,609,825 shares of Class A common stock. The remaining RSUs from this grant vest in equal 6.25% quarterly installments through January 1, 2027, contingent on continued service.

Positive

  • None.

Negative

  • None.
Insider Toy Andrew
Role Chief Executive Officer
Sold 313,476 shs ($1.67M)
Type Security Shares Price Value
Sale Class A Common Stock 313,476 $5.32 $1.67M
Holdings After Transaction: Class A Common Stock — 9,609,825 shares (Direct)
Footnotes (1)
  1. F1. The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units ("RSUs") originally granted to the Reporting Person on January 1, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Shares sold 313,476 shares Class A Common Stock sold on July 1, 2026
Sale price per share $5.32 per share Open-market sale to cover tax withholding
Shares held after transaction 9,609,825 shares Direct Class A holdings following the reported sale
RSU vesting rate 6.25% per quarter RSUs granted January 1, 2023, vest quarterly through 2027
restricted stock units ("RSUs") financial
"in connection with the vesting of 6.25% of restricted stock units ("RSUs") originally granted"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
sell to cover financial
"require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
equity incentive plans financial
"the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations"
Equity incentive plans are company programs that pay employees, executives, or directors with company stock, stock options, or share units instead of or in addition to cash, aiming to align their interests with shareholders—like giving team members a stake in the house they help build. For investors this matters because such plans can motivate better company performance but also dilute existing ownership and increase reported compensation costs, so they affect future earnings, voting power, and share value.
tax withholding obligations financial
"shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Clover Health (CLOV) report for CEO Andrew Toy?

Clover Health reported that CEO Andrew Toy sold 313,476 Class A shares at $5.32 per share. The sale was made to cover tax withholding obligations arising from RSU vesting under the company’s equity incentive plans.

Why did Clover Health (CLOV) CEO Andrew Toy sell 313,476 shares?

The shares were sold to cover tax withholding obligations from the vesting of restricted stock units granted on January 1, 2023. The transaction followed a mandated “sell to cover” election, so it was not a discretionary trade by the CEO.

How many Clover Health (CLOV) shares does CEO Andrew Toy hold after this sale?

After the tax-related sale, CEO Andrew Toy directly holds 9,609,825 shares of Clover Health Class A common stock. This figure comes from the reported post-transaction holdings in the insider trading disclosure.

What are the vesting terms of Andrew Toy’s RSUs at Clover Health (CLOV)?

The RSUs originally granted on January 1, 2023 vest in equal 6.25% installments each quarter. Vesting continues until a final vesting date of January 1, 2027, provided Andrew Toy remains in service through each vesting date.

Was the Clover Health (CLOV) CEO’s recent share sale discretionary?

No, the filing states the sale did not represent discretionary trades by Andrew Toy. It was required under Clover Health’s equity incentive plans to fund tax withholding via a mandated “sell to cover” transaction on RSU vesting.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Toy Andrew

(Last)(First)(Middle)
C/O CLOVER HEALTH INVESTMENTS, CORP.
NOT APPLICABLE

(Street)
WILMINGTON DELAWARE 19801

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CLOVER HEALTH INVESTMENTS, CORP. /DE [ CLOV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock07/01/2026S313,476(1)D$5.329,609,825D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units ("RSUs") originally granted to the Reporting Person on January 1, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Remarks:
/s/Peter J. Rivas as attorney-in-fact for Andrew Toy07/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)